Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132793) titled 'Diagnostic value of Trop2-targeted immuno-PET/CT in disease postoperative assessment of papillary thyroid carcinoma' on Sept. 18.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: jiangxi cancer hospital
Condition:
Papillary Thyroid Carcinoma
Intervention:
Gold Standard:Histopathological findings from biopsy and cytological results from puncture
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-23
Target Sample Size: Target condition:60;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr....